Barclays initiates coverage of Alcon stock at Equal Weight

Published on 10/08/2026 at 11:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Barclays set a USD 70.00 target on October 6, 2026. Alcon stock costs EUR 55.61 on October 8, 2026, and Q2 revenue was USD 2.82 billion.

Pop art comic book style wide horizontal illustration. Large cartoon eye with bold black outlines, iris in cyan and magenta Ben-Day halftone dots, graphic black lashes, yellow halftone background with radiating speed lines — Alcon CH0432492467: Pop Art Auge mit Halftone Punkten, Comic Wimpern und Speedlines auf gelbem Hintergrund, Illustration mit AI erstellt.

Alcon stock (ISIN CH0432492467) was trading at EUR 55.61 at Lang & Schwarz on October 8, 2026 at 11:19 a.m. CEST. Markets Insider reported that Barclays initiated coverage on October 6, 2026 with an Equal Weight rating and a USD 70.00 price target. The rating gives investors a concrete reference point while the euro quote remains below the analyst target expressed in U.S. dollars.

Barclays starts coverage

Barclays analyst Christopher Pasquale initiated coverage with an Equal Weight recommendation and a USD 70.00 target, according to Markets Insider on October 6, 2026. The note described stabilizing fundamentals in 2027 as a potential driver of sentiment, while also pointing to recent weakness across the medical suppliers and devices sector.

The target is distinct from the reference quote because it is denominated in USD, whereas the Lang & Schwarz price is denominated in EUR. That currency separation prevents a direct percentage-distance calculation between the two figures.

Second-quarter figures set the base

Alcon's quarter ended June 30, 2026 produced USD 2.82 billion in revenue, up from USD 2.77 billion consensus, while adjusted earnings per share reached USD 0.84 versus USD 0.77 expected, according to EarningsToday. The earnings-per-share comparison amounts to USD 0.07 above consensus, or 9.09 percent using the consensus figure as the base.

Alcon's investor-relations page describes two operating pillars, Surgical and Vision Care, serving customers in more than 140 countries. The company employs more than 25,000 associates and develops products for cataract surgery, contact lenses, dry eye and other eye-care needs.

Euro quote remains the reference

The Lang & Schwarz quote stood at EUR 55.61 on October 8, 2026 at 11:19 a.m. CEST. On SIX, Alcon was quoted at CHF 52.78 at 12:29 p.m. CEST on October 7, 2026, according to finanzen.ch. The Swiss quote is separate market context and does not replace the euro reference price.

The further course of trading is shown by the continuously updated real-time quote of Alcon stock.